Literature DB >> 12531698

Ligand- and kinase activity-independent cell survival mediated by the epidermal growth factor receptor expressed in 32D cells.

Jonathan A Ewald1, John C Wilkinson, Cheryl A Guyer, James V Staros.   

Abstract

To investigate the intrinsic activities of the epidermal growth factor receptor and the role of its kinase domain in these functions within a cellular environment lacking endogenous ErbB protein expression, wild-type EGF receptor (WT-EGFR) and two kinase-impaired mutants, D813A and K721R, were expressed in 32D murine hematopoietic cells, a line which is normally dependent on interleukin 3 (IL3) for growth and survival. Addition of EGF in the absence of IL3 stimulates receptor autophosphorylation and, in the presence of serum, mitosis in cells expressing WT-EGFR, but not in cells expressing D813A or K721R. Unexpectedly, cells expressing WT-EGFR or K721R exhibited IL3-independent survival in the presence of fetal bovine serum; parental 32D cells and cells expressing D813A did not survive, apparently undergoing apoptosis in the absence of IL3, whether or not serum was present. Addition of EGF did not prevent the apoptosis of WT-EGFR or K721R cells in serum-free medium. Activation of Akt was not necessary to mediate the prosurvival activity of EGF receptor expression. These results suggest that the EGF receptor can mediate the prevention of apoptosis independently of both receptor-ligand binding and receptor kinase activity, and this activity is disrupted by the D813A mutation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12531698     DOI: 10.1016/s0014-4827(02)00014-9

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  18 in total

Review 1.  Landscape of EGFR signaling network in human cancers: biology and therapeutic response in relation to receptor subcellular locations.

Authors:  Woody Han; Hui-Wen Lo
Journal:  Cancer Lett       Date:  2012-01-17       Impact factor: 8.679

2.  Afatinib restrains K-RAS-driven lung tumorigenesis.

Authors:  Herwig P Moll; Klemens Pranz; Monica Musteanu; Beatrice Grabner; Natascha Hruschka; Julian Mohrherr; Petra Aigner; Patricia Stiedl; Luka Brcic; Viktoria Laszlo; Daniel Schramek; Richard Moriggl; Robert Eferl; Judit Moldvay; Katalin Dezso; Pedro P Lopez-Casas; Dagmar Stoiber; Manuel Hidalgo; Josef Penninger; Maria Sibilia; Balázs Győrffy; Mariano Barbacid; Balázs Dome; Helmut Popper; Emilio Casanova
Journal:  Sci Transl Med       Date:  2018-06-20       Impact factor: 17.956

Review 3.  EGFR-dependent mechanisms in glioblastoma: towards a better therapeutic strategy.

Authors:  Cristina Zahonero; Pilar Sánchez-Gómez
Journal:  Cell Mol Life Sci       Date:  2014-03-27       Impact factor: 9.261

4.  Decreased skp2 expression is necessary but not sufficient for therapy-induced senescence in prostate cancer.

Authors:  Jonathan A Ewald; David F Jarrard
Journal:  Transl Oncol       Date:  2012-08-01       Impact factor: 4.243

5.  A kinase-independent role for EGF receptor in autophagy initiation.

Authors:  Xiaojun Tan; Narendra Thapa; Yue Sun; Richard A Anderson
Journal:  Cell       Date:  2015-01-15       Impact factor: 41.582

6.  Survival of cancer cells is maintained by EGFR independent of its kinase activity.

Authors:  Zhang Weihua; Rachel Tsan; Wei-Chien Huang; Qiuyu Wu; Chao-Hua Chiu; Isaiah J Fidler; Mien-Chie Hung
Journal:  Cancer Cell       Date:  2008-05       Impact factor: 31.743

7.  Epidermal growth factor receptor plays a significant role in hepatocyte growth factor mediated biological responses in mammary epithelial cells.

Authors:  Alyssa R Bonine-Summers; Mary E Aakre; Kimberly A Brown; Carlos L Arteaga; Jennifer A Pietenpol; Harold L Moses; Nikki Cheng
Journal:  Cancer Biol Ther       Date:  2007-04       Impact factor: 4.742

8.  Inhibition of DYRK1A destabilizes EGFR and reduces EGFR-dependent glioblastoma growth.

Authors:  Natividad Pozo; Cristina Zahonero; Paloma Fernández; Jose M Liñares; Angel Ayuso; Masatoshi Hagiwara; Angel Pérez; Jose R Ricoy; Aurelio Hernández-Laín; Juan M Sepúlveda; Pilar Sánchez-Gómez
Journal:  J Clin Invest       Date:  2013-05-01       Impact factor: 14.808

9.  Modeling human prostate cancer progression in vitro.

Authors:  Teresa T Liu; Jonathan A Ewald; Emily A Ricke; Robert Bell; Colin Collins; William A Ricke
Journal:  Carcinogenesis       Date:  2019-07-20       Impact factor: 4.944

Review 10.  Stress-Induced EGFR Trafficking: Mechanisms, Functions, and Therapeutic Implications.

Authors:  Xiaojun Tan; Paul F Lambert; Alan C Rapraeger; Richard A Anderson
Journal:  Trends Cell Biol       Date:  2016-01-27       Impact factor: 20.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.